Melissa M Meyer1, Alexander Schmidt2,3, Justus Benrath4, Simon Konstandin5, Lothar R Pilz6, Michael G Harrington7, Johannes Budjan2, Mathias Meyer2, Lothar R Schad8, Stefan O Schoenberg2, Stefan Haneder9. 1. Institute of Clinical Radiology and Nuclear Medicine, Medical Faculty Mannheim, University of Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany. melissa.ong@gmx.de. 2. Institute of Clinical Radiology and Nuclear Medicine, Medical Faculty Mannheim, University of Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany. 3. Department of Diagnostic and Interventional Radiology, University of Würzburg, Würzburg, Germany. 4. Clinic for Anaesthesiology and Operative Intensive Care, University of Heidelberg, Mannheim, Germany. 5. MR-Imaging and Spectroscopy, Fraunhofer MEVIS, Bremen, Germany. 6. Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany. 7. Huntington Medical Research Institutes, Pasadena, CA, USA. 8. Computer Assisted Clinical Medicine, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany. 9. Department of Radiology, University Hospital of Cologne, Cologne, Germany.
Abstract
OBJECTIVE: Evaluation of MRI-derived cerebral 23Na concentrations in patients with migraine in comparison with healthy controls. MATERIALS AND METHODS: In this case-control study, 24 female migraine patients (mean age, 34 ± 11 years) were enrolled after evaluation of standardized questionnaires. Half (n = 12) of the cohort suffered from migraine, the other half was impaired by both migraine and tension-type headaches (TTH). The combined patient cohort was matched to 12 healthy female controls (mean age, 34 ± 11 years). All participants underwent a cerebral 23Na-magnetic resonance imaging examination at 3.0 T, which included a T1w MP-RAGE sequence and a 3D density-adapted, radial gradient echo sequence for 23Na imaging. Circular regions of interests were placed in predetermined anatomic regions: cerebrospinal fluid (CSF), gray and white matter, brain stem, and cerebellum. External 23Na reference phantoms were used to calculate the total 23Na tissue concentrations. Pearson's correlation, Kendall Tau, and Wilcoxon rank sum test were used for statistical analysis. RESULTS: 23Na concentrations of all patients in the CSF were significantly higher than in healthy controls (p < 0.001). The CSF of both the migraine and mixed migraine/TTH group showed significantly increased sodium concentrations compared to the control group (p = 0.007 and p < 0.001). Within the patient cohort, a positive correlation between pain level and TSC in the CSF (r = 0.62) could be observed. CONCLUSION: MRI-derived cerebral 23Na concentrations in the CSF of migraine patients were found to be statistically significantly higher than in healthy controls. KEY POINTS: • Cerebral sodium MRI supports the theory of ionic imbalances and may aid in the challenging pathophysiologic understanding of migraine. • Case-control study shows significantly higher sodium concentrations in cerebrospinal fluid of migraineurs. • Cerebral sodium MRI may become a non-invasive imaging tool for drugs to modulate sodium, and hence migraine, on a molecular level, and influence patient management.
OBJECTIVE: Evaluation of MRI-derived cerebral 23Na concentrations in patients with migraine in comparison with healthy controls. MATERIALS AND METHODS: In this case-control study, 24 female migrainepatients (mean age, 34 ± 11 years) were enrolled after evaluation of standardized questionnaires. Half (n = 12) of the cohort suffered from migraine, the other half was impaired by both migraine and tension-type headaches (TTH). The combined patient cohort was matched to 12 healthy female controls (mean age, 34 ± 11 years). All participants underwent a cerebral 23Na-magnetic resonance imaging examination at 3.0 T, which included a T1w MP-RAGE sequence and a 3D density-adapted, radial gradient echo sequence for 23Na imaging. Circular regions of interests were placed in predetermined anatomic regions: cerebrospinal fluid (CSF), gray and white matter, brain stem, and cerebellum. External 23Na reference phantoms were used to calculate the total 23Na tissue concentrations. Pearson's correlation, Kendall Tau, and Wilcoxon rank sum test were used for statistical analysis. RESULTS:23Na concentrations of all patients in the CSF were significantly higher than in healthy controls (p < 0.001). The CSF of both the migraine and mixed migraine/TTH group showed significantly increased sodium concentrations compared to the control group (p = 0.007 and p < 0.001). Within the patient cohort, a positive correlation between pain level and TSC in the CSF (r = 0.62) could be observed. CONCLUSION: MRI-derived cerebral 23Na concentrations in the CSF of migrainepatients were found to be statistically significantly higher than in healthy controls. KEY POINTS: • Cerebral sodium MRI supports the theory of ionic imbalances and may aid in the challenging pathophysiologic understanding of migraine. • Case-control study shows significantly higher sodium concentrations in cerebrospinal fluid of migraineurs. • Cerebral sodium MRI may become a non-invasive imaging tool for drugs to modulate sodium, and hence migraine, on a molecular level, and influence patient management.
Entities:
Keywords:
Cerebrospinal fluid; Magnetic resonance imaging; Migraine; Sodium
Authors: Xianghong Arakaki; Hailey Foster; Lei Su; Huy Do; Andrew J Wain; Alfred N Fonteh; Feimeng Zhou; Michael G Harrington Journal: Brain Res Date: 2011-05-23 Impact factor: 3.252
Authors: Stefan Haneder; Simon Konstandin; John N Morelli; Armin M Nagel; Frank G Zoellner; Lothar R Schad; Stefan O Schoenberg; Henrik J Michaely Journal: Radiology Date: 2011-07-19 Impact factor: 11.105
Authors: Ronald Ouwerkerk; Karen B Bleich; Joseph S Gillen; Martin G Pomper; Paul A Bottomley Journal: Radiology Date: 2003-03-27 Impact factor: 11.105
Authors: C Fernández-de-las-Peñas; P Madeleine; A B Caminero; M L Cuadrado; L Arendt-Nielsen; J A Pareja Journal: Cephalalgia Date: 2010-01 Impact factor: 6.292
Authors: Friedrich Wetterling; Eva Chatzikonstantinou; Laurent Tritschler; Stephen Meairs; Marc Fatar; Lothar R Schad; Saema Ansar Journal: BMC Neurosci Date: 2016-12-07 Impact factor: 3.288
Authors: Aashim Bhatia; Vincent Kyu Lee; Yongxian Qian; Michael J Paldino; Rafael Ceschin; Jasmine Hect; James M Mountz; Dandan Sun; Gary Kohanbash; Ian F Pollack; Regina I Jakacki; Fernando Boada; Ashok Panigrahy Journal: Diagnostics (Basel) Date: 2022-05-13
Authors: Muhammad H Khan; John J Walsh; Jelena M Mihailović; Sandeep K Mishra; Daniel Coman; Fahmeed Hyder Journal: Sci Rep Date: 2021-03-23 Impact factor: 4.379